Speech-Language Pathologists in Wood River, IL Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Kristine Lynn Hagen, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 E Lorena Ave, Wood River, IL 62095 Phone: 618-254-0607

Shea Whitney Guss, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 E Lorena Ave, Wood River, IL 62095 Phone: 618-254-0607

Purple Giraffe Speech Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 519 George St, Wood River, IL 62095 Phone: 618-531-3685

Madge Strohmeier, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 519 George St, Wood River, IL 62095 Phone: 618-531-3685

Jodi Lyn Gilmore, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 E Lorena Ave, Wood River, IL 62095 Phone: 618-254-4354

News Archive

Global interconnectedness influences population health

In a global health review article in the New England Journal of Medicine, Anthony McMichael of the National Centre for Epidemiology and Population Health at the Australian National University examines the effects of globalization and "international connectivity" on "human health, international health care, and public health activities."

Research on how cells cope with stress could lead to more effective cancer treatment

Both radiation and many forms of chemotherapy try to kill tumors by causing oxidative stress in cancer cells. New research from USC on a protein that protects cancer and other cells from these stresses could one day help doctors to break down cancer cells' defenses, making them more susceptible to treatment.

University of Utah professor develops MORE intervention program for chronic pain patients

How can people who are dependent on prescription opioids reduce their cravings? Learn to enjoy other aspects of their lives.

Alnylam and Medtronic announce pre-clinical research findings from their Huntington's disease program

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT), the world's leading developer of medical devices, announced today the presentation of new pre-clinical research findings from their Huntington's disease program at the 2009 World Congress on Huntington's Disease held September 12-15, 2009 in Vancouver, British Columbia.

Research points to potential new treatment for hearing loss

Researchers have taken an important step toward what may become a new approach to restore the hearing loss. In a new study, out today in the European Journal of Neuroscience, scientists have been able to regrow the sensory hair cells found in the cochlea - a part of the inner ear - that converts sound vibrations into electrical signals and can be permanently lost due to age or noise damage.

Read more Medical News

› Verified 6 days ago